Response to letters to the Editor on 'Abemaciclib plus a nonsteroidal aromatase inhibitor as initial therapy for HR+, HER2- advanced breast cancer: final overall survival results of MONARCH 3'.
作者信息
Goetz M P, André V, Johnston S R D
机构信息
Department of Oncology, Mayo Clinic, Rochester.
Eli Lilly and Company, Indianapolis, USA.
出版信息
Ann Oncol. 2024 Dec;35(12):1202-1204. doi: 10.1016/j.annonc.2024.08.2350. Epub 2024 Oct 15.
Abstract
摘要
Zotero 插件